NASS 2019 Annual Meeting

Jim Youssef, MD




Board of Directors: Society of Lateral Access Surgery (SOLAS) (None, Past-president); Consulting: CTL/Amedica (A), Healthtrust (A), Nuvasive (D), Providence Medical (None), Seaspine (None); Research Support (Staff and/or materials): Globus Medical (C, Paid directly to institution/employer), Medtronic (B, Paid directly to institution/employer), Nuvasive (D, Paid directly to institution/employer), Providence Medical (B, Paid directly to institution/employer), Seaspine (C, Paid directly to institution/employer), SOLAS (C, Paid directly to institution/employer), Vertiflex (B, Paid directly to institution/employer); Royalties: CTL/Amedica (C), Nuvasive (F), Osprey Biomedical (B, Outside 12-Month Requirement), Seaspine (C); Stock Ownership: Nuvasive (G, 19,000 options), Nuvasive (8,000 shares), Providence Medical (None, 1,000 stock options).

Sessions :